In this meta-analysis, investigators evaluated poly adenosine diphosphate ribose polymerase inhibitors as maintenance therapy for patients with newly diagnosed advanced ovarian cancer. The review ...
AN INSIGHTFUL study suggests that certain oral molecularly targeted cancer therapies may increase the risk of progressive kidney dysfunction over two years, even when an early rise in serum creatinine ...
Perhaps the most intriguing implication of recent breakthrough research lies in an unexpected connection: the most rigorous mechanistic dissection of rapid antidepressant action identifies adenosine ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Adenosine triphosphate (ATP) and its breakdown products, including adenosine, play key ...
Migliavacca M, Barzaghi F, Fossati C, et al. Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency. Nat Med 2024;30:488-497.
DOVER, Del., April 28, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company today reports confirmatory preclinical efficacy data for PORT-7 (TT-4), a ...
Portage Biotech Inc. (NASDAQ:PRTG) on Thursday presented new preclinical data for PORT-7 (TT-4), a selective Adenosine A2B receptor inhibitor, at the 2025 European Lung Cancer Congress. The new data ...
1 Marine College, Shandong University, Weihai, China 2 Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China Recent studies on the ...
ABSTRACT: One of the sparkling features of either micro (subatomic) or macro (cosmic) attribute of cyclic or elliptical movement can be regarded a translational movement of golden ratio rated golden ...
Poly adenosine diphosphate-ribose polymerase inhibitors, an important class of anticancer drugs, employ synthetic lethality strategy and are particularly effective against cancers with genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results